Magnitude and Kinetics of Decrease in Liver Stiffness After Antiviral Therapy in Patients With Chronic Hepatitis C: A Systematic Review and Meta-analysis
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
BACKGROUND & AIMS: We performed a systematic review and meta‐analysis to estimate the decrease in liver stiffness, measured by vibration‐controlled transient elastrography (VCTE), in patients with hepatitis C virus infection who achieved a sustained virologic response (SVR). METHODS: We searched the literature through October 2016 for observational studies or randomized controlled trials of adults with hepatitis C virus infection who received antiviral therapy (either direct‐acting antiviral agents or interferon‐based therapies), underwent liver stiffness measurement using VCTE before starting therapy, and had at least 1 follow‐up VCTE after completion of therapy; studies also provided data on mean or median liver stiffness measurements for patients who did and did not achieve an SVR. We identified 24 studies, and estimated weighted mean difference (and 95% confidence interval) in liver stiffness in patients with versus without SVR using random‐effects meta‐analysis. RESULTS: In patients who achieved SVR, liver stiffness decreased by 2.4 kPa at the end of therapy (95% CI, −1.7 to −3.0), by 3.1 kPa 1–6 months after therapy (95% CI, −1.6 to −4.7), by 3.2 kPa 6–12 months after therapy (90% CI, −2.6 to −3.9), and 4.1 kPa 12 months or more after therapy (95% CI, −3.3 to −4.9) (median decrease, 28.2%; interquartile range, 21.8–34.8). In contrast, there was no significant change in liver stiffness in patients who did not achieve an SVR (at 6–12 months after therapy, decrease of 0.6 kPa; 95% CI, −1.7 to 0.5). Decreases in liver stiffness were significantly greater in patients treated with direct‐acting antiviral agents than with interferon‐based therapy (decrease of 4.5 kPa vs decrease of 2.6 kPa; P = .03), cirrhosis at baseline (decrease of 5.1 kPa vs decrease of 2.8 kPa in patients with no cirrhosis; P = .02), or high pretreatment levels of alanine aminotransferase (P < .01). Among patients with baseline liver stiffness >9.5 kPa, 47% (95% CI, 27%–68%) achieved posttreatment liver stiffness of <9.5 kPa. CONCLUSIONS: In a systematic review and meta‐analysis, we associated eradication of hepatitis C virus infection (SVR) with significant decreases in liver stiffness, particularly in patients with high baseline level of inflammation or patients who received direct‐acting antiviral agents. Almost half the patients considered to have advanced fibrosis, based on VCTE, before therapy achieved posttreatment liver stiffness levels <9.5 kPa. Clinical Trial Registration no: CRD42016051034.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PRISMA-P Group, Moher, D., Shamseer, L., Clarke, M., Ghersi, D., Liberati, A., Petticrew, M., Shekelle, P., & Stewart, L. A. (2015) · Systematic Reviews · doi:10.1186/2046-4053-4-1 · Cited by 26,223
Cited by
Berzigotti, A., Tsochatzis, E., Boursier, J., Castera, L., Cazzagon, N., Friedrich-Rust, M., Petta, S., & Thiele, M. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2021.05.025 · Cited by 1,925
“8), 6–12 months after the end of therapy in SVR patients whereas no change was observed in non SVR patients [81].”
BackgroundImpact of non-invasive biomarkers on hepatology practice: past, present and future
Anstee, Q. M., Castera, L., & Loomba, R. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2022.03.026 · Cited by 224
Self-citationAkkız, H., Gieseler, R. K., & Canbay, A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25147873 · Cited by 191
“The regression of liver fibrosis in patients with HCV-related liver cirrhosis with a sustained virological response upon DAA treatment could be demonstrated by related pathological parameters and/or by measuring liver stiffness with transient elastography (FibroScan) [221,222].”
BackgroundA critical review of endpoints for non-cirrhotic NASH therapeutic trials
Ratziu, V. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2017.12.001 · Cited by 74
Pan, J. J., Bao, F., Du, E., Skillin, C., Frenette, C. T., Waalen, J., Alaparthi, L., Goodman, Z. D., & Pockros, P. J. (2018) · Hepatology Communications · doi:10.1002/hep4.1228 · Cited by 70
Metadata
- Authors
- Singh, S., Facciorusso, A., Loomba, R., & Falck-Ytter, Y. T.
- Venue
- Clinical Gastroenterology and Hepatology
- Publisher
- Elsevier BV
- Published
- 2018-01
- Volume
- 16
- Issue
- 1
- Pages
- 27-38.e4
- ISSN
- 1542-3565 (ISSN-L)
- OpenAlex
- W2610988825
- Cited by
- 208
- References
- 1
- FWCI
- 3.14
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.